Forte Biosciences

Forte Biosciences

Yahoo Finance • 5 days ago

Halper Sadeh LLC is Investigating Whether FBRX and SAFT are Obtaining Fair Deals for their Shareholders

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. Shareholders are encouraged to contact the firm... Full story

Yahoo Finance • 6 days ago

argenx signs agreement to buy Forte Biosciences for $2.2bn

argenx has entered a definitive agreement to acquire Forte Biosciences for approximately $2.2bn in total equity value. Approved by both companies' boards of directors, the transaction is expected to close in the third quarter of 2026, con... Full story

Yahoo Finance • 6 days ago

Top Biotech Gainers: GOSS To File Seralutinib NDA In Sep, OMER Gains On AZN's Loss, FBRX Acquired

(RTTNews) - Today's top biotech gainers include Entera Bio, following an oversubscribed private placement financing; Gossamer, which is progressing toward a planned Seralutinib NDA submission in September; First Tracks, which has been firi... Full story

Yahoo Finance • 6 days ago

Stocks Settle Mixed as AI Angst Offsets Easing Geopolitical Tensions

The S&P 500 Index ($SPX) (SPY) on Monday closed up +0.02%, the Dow Jones Industrial Average ($DOWI) (DIA) closed up +0.51%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed down -0.32%.  September E-mini S&P futures (ESU26) rose +0.02%, and S... Full story

Yahoo Finance • 6 days ago

Stocks Fall from Early Highs as Chipmakers Retreat

The S&P 500 Index ($SPX) (SPY) today is up +0.11%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +0.54%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -0.46%.  September E-mini S&P futures (ESU26) are up +0.11%, and September E-min... Full story

Yahoo Finance • 6 days ago

Stocks making the biggest moves midday: ASML, SK Hynix, SAP, Forte Bio, Brown-Forman & more

Check out some of the companies making the biggest moves midday: ASML — The maker of semiconductor manufacturing equipment slid 8%. China began mass production of domestically made deep ultraviolet chipmaking tools, The Information reporte... Full story

Yahoo Finance • 6 days ago

Stocks Rally as Middle East Tensions Ease

The S&P 500 Index ($SPX) (SPY) today is up +0.65%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +1.08%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +0.56%.  September E-mini S&P futures (ESU26) are up +0.65%, and September E-mini... Full story

Yahoo Finance • 7 days ago

Stocks making the biggest moves premarket: Micron Technology, Forte Biosciences, ExxonMobil, Baker Hughes & more

Check out the companies making the biggest moves premarket: Memory stocks — Shares rose broadly after chipmaker CXMT made its public market debut in Shanghai , with its stock skyrocketing more than 466%. The momentum carried over into U.S.... Full story

Yahoo Finance • 7 days ago

argenx to Acquire Forte Biosciences, Inc., Adding First-in-Class anti-CD122 Antibody, FB102, to its Immunology Pipeline

Transaction builds on argenx’s prior strategic investment in Forte Biosciences and reflects a disciplined approach to accessing novel biology that can fuel long-term growthFB102 Phase 1b studies in vitiligo and celiac disease validate CD12... Full story

Yahoo Finance • 13 days ago

Should You Be Bullish on Forte Biosciences (FBRX)

Fred Alger Management, an investment management company, released its "Alger Mid Cap Focus Fund" second-quarter 2026 investor letter. A copy of the letter can be downloaded here. U.S. equities experienced a strong recovery in Q2 2026, with... Full story

Yahoo Finance • 24 days ago

Top Biotech Gainers: VRAX Jumps 100% After Fosun Deal, FBRX Soars On Vitiligo Data, TRAX On Watch

(RTTNews) - Today's top biotech gainers include Virax Biolabs, following its agreement with Fosun Diagnostics; Forte Biosciences, after reporting positive vitiligo data; Connect Biopharma, with a key near-term catalyst ahead; and SANUWAVE... Full story

Yahoo Finance • 25 days ago

Enovix, Forte Biosciences rally premarket; PepsiCo slips

Investing.com - U.S. stock index futures were mixed on Thursday as investors weighed escalating tensions between the United States and Iran against a continued rebound in semiconductor shares. By 07:09 ET (11:09 GMT), the Dow futures cont... Full story

Yahoo Finance • last year

Forte Biosciences Announces Pricing of $75 Million Public Offering

DALLAS--(BUSINESS WIRE)--Forte Biosciences, Inc. (Nasdaq: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced the pricing of a public offering of 5,630,450 shares of its... Full story

Yahoo Finance • last year

Forte's celiac disease drug shows positive results in Phase 1b trial

DALLAS - Forte Biosciences, Inc. (NASDAQ:FBRX), a clinical-stage biotech company with a market capitalization of $96.51 million, reported positive data from a Phase 1b trial of its lead drug candidate FB102 for celiac disease, according to... Full story

Yahoo Finance • 3 years ago

Jasper Therapeutics Appoints Scott Brun, M.D., to its Board of Directors

Dr. Brun also appointed as Chairperson of Jasper Research and Development Committee and to Compensation Committee Board member Vishal Kapoor appointed to Jasper Audit and Compensation Committees REDWOOD CITY, Calif., June 20, 2023 (GLO... Full story

Yahoo Finance • 4 years ago

Mr. David Gryska Appointed to Forte Biosciences Board of Directors

-Addition of Mr. David Gryska Further Strengthens Forte Board of Directors DALLAS, January 12, 2023--(BUSINESS WIRE)--Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), announced today that Mr. David Gryska has been appointed to... Full story